Evogene (EVGN) Tops Q2 EPS by 19c

Evogene (NASDAQ: EVGN) reported Q2 EPS of ($1.06), $0.19 better than the analyst estimate of ($1.25). Revenue for the quarter came in at $914 thousand versus the consensus estimate of $775 thousand.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• Nelson Peltz Prepares Bid For Wendy’s - FT
• JD.com (JD) call put ratio 2.1 calls to 1 put with a focus on September 37 calls into quarter results
• Dyadic International, Inc. (DYAI) Misses Q2 EPS by 2c